Loading...
•
Jul 03, 2021
Perrigo Q2 2021 Earnings Report
Perrigo's Q2 2021 financial results from continuing operations were reported.
Key Takeaways
Perrigo's Q2 2021 net sales increased by 3.4% to $981 million, driven by growth in most businesses and favorable currency movements, but adjusted EPS decreased by 15.3% to $0.50 due to reinstatement of brand and marketing investments.
Perrigo reaffirmed its fiscal 2021 net sales guidance.
Adjusted EPS is now expected towards the lower end of the guidance range due to lower sales volumes and higher input costs.
U.S. and E.U. Consumer Self-Care Take Away Rebounded Sharply in the Quarter.
Divestiture of RX Business for $1.55 Billion Completed on July 6, 2021, Providing Significant Cash for Driving Business Growth.
Revenue by Segment
Forward Guidance
The Company reaffirmed its fiscal 2021 organic net sales growth outlook of 3% and now expects adjusted diluted EPS towards the lower end of its adjusted diluted EPS range of $2.50 to $2.70.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...